Clinical trial
Pharmacokinetics of LY3314814 in Subjects With Hepatic Impairment
NCT03499041 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacokinetics of LY3314814 in Subjects With Hepatic Impairment
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- June 30, 2018
- Completion date
- December 31, 2018
- Enrollment
- 0 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
hepatic impairment